300015 爱尔眼科
已收盘 04-09 15:00:00
资讯
新帖
简况
爱尔眼科：公司管理层包括唐仕波教授、杨智宽教授等知名眼科专家
证券之星 · 04-09 16:06
爱尔眼科：公司管理层包括唐仕波教授、杨智宽教授等知名眼科专家
爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益
证券之星 · 04-03
爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益
爱尔眼科：推进1+8+N战略，完善国际化布局
证券之星 · 04-02
爱尔眼科：推进1+8+N战略，完善国际化布局
爱尔眼科：积极推进“1+8+N”战略
证券之星 · 03-30
爱尔眼科：积极推进“1+8+N”战略
Clinica Baviera拟派发每股1.57欧元股息
投资观察 · 03-26
Clinica Baviera拟派发每股1.57欧元股息
股市必读：爱尔眼科（300015）3月25日董秘有最新回复
证券之星 · 03-26
股市必读：爱尔眼科（300015）3月25日董秘有最新回复
Clinica Baviera任命Luis Gravalos Soria为新任首席执行官，即时生效
投资观察 · 03-25
Clinica Baviera任命Luis Gravalos Soria为新任首席执行官，即时生效
爱尔眼科：完善学科建设开设老视门诊
证券之星 · 03-25
爱尔眼科：完善学科建设开设老视门诊
爱尔眼科：公司将在保障日常经营与长期发展的前提下，稳步提升分红力度
证券之星 · 03-23
爱尔眼科：公司将在保障日常经营与长期发展的前提下，稳步提升分红力度
爱尔眼科：公司追求高质量发展、可持续回报
证券之星 · 03-20
爱尔眼科：公司追求高质量发展、可持续回报
爱尔眼科：新十年聚焦高质量发展
证券之星 · 03-19
爱尔眼科：新十年聚焦高质量发展
爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级
证券日报 · 03-18
爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级
爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司
证券之星 · 03-18
爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司
爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%
证券之星 · 03-16
爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%
股市必读：爱尔眼科（300015）3月11日董秘有最新回复
证券之星 · 03-12
股市必读：爱尔眼科（300015）3月11日董秘有最新回复
新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准
智通财经 · 03-09
新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准
爱尔眼科：油价变化与眼科耗材相关度极低
证券之星 · 03-06
爱尔眼科：油价变化与眼科耗材相关度极低
爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%
朝阳永续 · 03-03
爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%
爱尔眼科：成立多学科合作的老视学组
证券之星 · 03-02
爱尔眼科：成立多学科合作的老视学组
巴伐利亚眼科全年净利润达4210万欧元
投资观察 · 02-28
巴伐利亚眼科全年净利润达4210万欧元
加载更多
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":9.5,"timestamp":1775718231000,"preClose":9.72,"halted":0,"volume":50477020,"delay":0,"changeRate":-0.0226,"floatShares":7955000000,"shares":9325000000,"eps":0.3452,"marketStatus":"已收盘","change":-0.22,"latestTime":"04-09 15:00:00","open":9.64,"high":9.67,"low":9.48,"amount":482000000,"amplitude":0.0195,"askPrice":9.51,"askSize":635,"bidPrice":9.5,"bidSize":685,"shortable":0,"etf":0,"ttmEps":0.3452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.72,"symbolType":"stock","openAndCloseTimeList":[[1775698200000,1775705400000],[1775710800000,1775718000000]],"highLimit":10.69,"lowLimit":8.75,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":4.04,"roa":"--","peRate":27.520278,"roe":"14.32%","epsLYR":0.3847,"committee":0.43675,"marketValue":88591000000,"turnoverRate":0.0063,"status":1,"floatMarketCap":75576000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2626004904","title":"爱尔眼科：公司管理层包括唐仕波教授、杨智宽教授等知名眼科专家","url":"https://stock-news.laohu8.com/highlight/detail?id=2626004904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626004904?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:06","pubTimestamp":1775721967,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：细看管理层人员履历，发现贵司管理层均无医学背景，多数为管理类专业毕业，建议贵司上市名称变更为爱尔投资，这样更符合管理层的气质，同时也更能大胆多元化发展，力争在更多行业发光发热。望采纳。爱尔眼科回复：欢迎持续关注！公司管理层包括唐仕波教授、杨智宽教授等知名眼科专家，建议查阅公开信息！谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900024021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518857.USD","BK0114","BK0200","LU1820825898.SGD","BK0188","BK0113","LU1242518931.SGD","BK0012","LU1146622755.USD","BK0028","BK0077","BK0096","300015","LU0979878070.USD","BK0236","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624650578","title":"爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2624650578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624650578?lang=zh_cn&edition=full","pubTime":"2026-04-03 20:52","pubTimestamp":1775220773,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好!公司股价已连续下跌五年之久，目前股价这个位置，公司依然买理财，没有考虑要回购股份吗？难道公司也认为爱尔眼科估值依然过高？爱尔眼科回复：谢谢关注。公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益。后续如有进一步回购计划，将及时对外披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300041629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","300015","BK0114","BK0028","BK0188","BK0096","LU1146622755.USD","BK0196","LU1820825898.SGD","BK0113","LU0979878070.USD","BK0077","LU1242518857.USD","BK0012","BK0200","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624577316","title":"爱尔眼科：推进1+8+N战略，完善国际化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624577316?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:30","pubTimestamp":1775122225,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：爱尔眼科怎么了？业绩尚可，为什么股价一直在跌。请问一下公司有什么对策？爱尔眼科回复：谢谢关注。公司一手抓基本面的高质量发展，推进1+8+N”战略，完善国际化布局，一手抓市场面的持续沟通，让广大投资者进一步认识到眼科行业的巨大空间和公司的创新发展。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200030247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0114","BK0236","LU0979878070.USD","BK0188","BK0028","BK0200","300015","LU1146622755.USD","LU1242518857.USD","LU1820825898.SGD","BK0196","LU1242518931.SGD","BK0096","BK0077","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623541393","title":"爱尔眼科：积极推进“1+8+N”战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2623541393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623541393?lang=zh_cn&edition=full","pubTime":"2026-03-30 12:36","pubTimestamp":1774845373,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月30日在投资者关系平台上答复投资者关心的问题。知道贵公司对眼科领域是非常专注!公司积极推进“1+8+N”战略，积极稳健全球化布局，全面提升医疗水平和服务能力，加强学科建设、加快智慧赋能，为各年龄段的人群提供多层次、高质量的医疗服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000013160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0114","LU0979878070.USD","LU1820825898.SGD","BK0236","LU1242518931.SGD","BK0196","LU1146622755.USD","LU1242518857.USD","BK0077","BK0028","300015","BK0200","BK0096","BK0113","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154128835","title":"Clinica Baviera拟派发每股1.57欧元股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1154128835","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154128835?lang=zh_cn&edition=full","pubTime":"2026-03-26 01:04","pubTimestamp":1774458268,"startTime":"0","endTime":"0","summary":"3月25日 - 眼科医疗集团Clinica Baviera SA宣布，计划提议派发一项股息，该股息将计入2025财年的业绩。拟议的每股固定股息金额为1.57欧元（税前）。\n","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0113","300015","BK0096","BK0188","BK0012","LU1146622755.USD","BK0114","LU0979878070.USD","BK0028","BK0236","LU1242518931.SGD","LU1820825898.SGD","BK0077","BK0196","LU1242518857.USD","BK0200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622100538","title":"股市必读：爱尔眼科（300015）3月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2622100538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622100538?lang=zh_cn&edition=full","pubTime":"2026-03-26 00:58","pubTimestamp":1774457892,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，爱尔眼科报收于9.72元，上涨0.31%，换手率0.53%，成交量42.06万手，成交额4.08亿元。董秘最新回复投资者： 董秘你好，请问公司对“银发经济”有何发展战略？重大信息以公司公告为准。当日关注点来自交易信息汇总：3月25日主力资金净流出1954.99万元，散户资金净流入1779.4万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600001589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0196","LU0979878070.USD","BK0012","BK0236","BK0028","BK0077","300015","BK0188","BK0096","BK0114","LU1146622755.USD","LU1820825898.SGD","LU1242518857.USD","LU1242518931.SGD","BK0200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105208922","title":"Clinica Baviera任命Luis Gravalos Soria为新任首席执行官，即时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1105208922","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105208922?lang=zh_cn&edition=full","pubTime":"2026-03-25 21:51","pubTimestamp":1774446705,"startTime":"0","endTime":"0","summary":"3月25日——Clinica Baviera SA宣布，任命Luis Gravalos Soria为公司新任首席执行官，该决定自公布之日起立即生效。\n与此同时，Eduardo Baviera Sabater将继续担任公司副董事长职务，并保留其执行管理职责。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","300015","LU0979878070.USD","BK0196","BK0200","LU1820825898.SGD","BK0113","LU1242518857.USD","BK0096","BK0012","BK0114","LU1242518931.SGD","BK0236","BK0188","LU1146622755.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622175810","title":"爱尔眼科：完善学科建设开设老视门诊","url":"https://stock-news.laohu8.com/highlight/detail?id=2622175810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622175810?lang=zh_cn&edition=full","pubTime":"2026-03-25 08:45","pubTimestamp":1774399518,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)03月25日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问公司对“银发经济”有何发展战略？爱尔眼科回复：谢谢您对公司的关注。人口老龄化催生大量眼病新需求，公司发挥技术优势，完善学科建设，进一步开设老视门诊、糖尿病眼病等专病门诊，形成多学科合作（MDT）机制，持续为大众提供多层次、全周期的眼健康服务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500011057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1820825898.SGD","LU1242518857.USD","BK0028","LU1146622755.USD","BK0114","BK0188","BK0196","300015","BK0200","BK0077","LU0979878070.USD","BK0113","BK0096","BK0236","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621577579","title":"爱尔眼科：公司将在保障日常经营与长期发展的前提下，稳步提升分红力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2621577579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621577579?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:30","pubTimestamp":1774254651,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，一季度快结束了，想必寒假会给公司的眼科业务带来不少的收获，请问贵司新收购的公司业绩是否纳入一季度财报？另外贵司今年计划在股东投资回报方面有什么新的想法吗？谢谢爱尔眼科回复：谢谢您对公司的关注。公司根据相关规定确定并表时间。公司将在保障日常经营与长期发展的前提下，稳步提升分红力度，持续增强投资者获得感，届时请关注相关公告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","LU1242518857.USD","LU1820825898.SGD","BK0012","300015","BK0028","BK0114","LU1146622755.USD","BK0113","BK0188","BK0096","BK0196","BK0236","BK0200","LU0979878070.USD","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620173640","title":"爱尔眼科：公司追求高质量发展、可持续回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2620173640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620173640?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:51","pubTimestamp":1774011079,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月19日在投资者关系平台上答复投资者关心的问题。强烈建议贵司在1个月内推出在二级市场至少回购5亿元股票并注销的计划，回购价格建议不低于20元，如此必能振奋人心。公司追求高质量发展、可持续回报，发力科技创新、优质医疗，不断夯实基本面。未来如有进一步回购或增持计划，公司将按规定信息披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000040323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0113","BK0236","BK0196","LU1242518931.SGD","LU1146622755.USD","BK0096","BK0028","BK0114","BK0200","BK0012","BK0188","LU1242518857.USD","LU1820825898.SGD","300015","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620924538","title":"爱尔眼科：新十年聚焦高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620924538?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:21","pubTimestamp":1773912067,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月19日在投资者关系平台上答复投资者关心的问题。公司前十年通过内涵增长、外延扩张双轮驱动，快速完善网络布局，实现业绩稳步增长，服务网络已覆盖大多数城乡县域。新十年，公司聚焦高质量发展，持续推进“1+8+N”战略，进一步提升核心业务，优化区域医疗资源，加快数字化赋能，强化医疗能力和内在价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900028146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","LU0979878070.USD","BK0012","BK0188","BK0200","BK0236","LU1146622755.USD","BK0077","BK0113","LU1242518857.USD","LU1242518931.SGD","BK0096","300015","LU1820825898.SGD","BK0114","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620675256","title":"爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675256","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675256?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:38","pubTimestamp":1773837480,"startTime":"0","endTime":"0","summary":"证券日报网3月18日讯 ，爱尔眼科在接受调研者提问时表示，科技进步是推动医疗行业发展的重要驱动力。公司几年前已与科研机构合作成立数字眼科实验室，探索人工智能、大数据在眼病筛查、辅助诊断及医疗流程优化等场景中的应用，逐步向“前沿科技+眼科医院”的平台型医疗机构升级。公司的核心定位始终是以医疗服务为主的医院集团，是直接面向患者的重要服务入口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-18/doc-inhrmihr9322582.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-18/doc-inhrmihr9322582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0236","LU1146622755.USD","LU1820825898.SGD","BK0012","LU0979878070.USD","BK0200","BK0113","300015","BK0114","BK0077","BK0096","LU1242518931.SGD","BK0028","BK0196","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620189237","title":"爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2620189237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620189237?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:01","pubTimestamp":1773831675,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月18日爱尔眼科发布公告称大成基金戴军 陈泉龙 李博 侯春燕 杨挺 邹建 赵蓬 王晶晶、国泰海通证券陈铭 张澄于2026年3月17日调研我司。目前，公司海外业务收入占比约 13%左右，未来有望进一步突破。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800033715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK1147","BK0236","BK0183","BK0196","BK1564","BK0184","601211","LU1820825898.SGD","300015","BK0028","BK0200","BK0096","LU1242518931.SGD","BK0012","LU1146622755.USD","BK0114","BK0201","LU1242518857.USD","BK0276","LU0979878070.USD","02611","BK0077","161027","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619461882","title":"爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619461882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619461882?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:13","pubTimestamp":1773670399,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，爱尔眼科报收于10.29元，较前一交易日上涨1.28%，最新总市值为959.58亿元。爱尔眼科医院集团股份有限公司于2026年3月16日发布公告，公司控股股东爱尔医疗投资集团有限公司将其持有的109,494,149股公司股份解除质押，占其所持股份比例3.42%，占公司总股本比例1.17%，质押起始日为2020年12月21日，解除日期为2026年3月13日，质权人为深圳平安汇通投资管理有限公司。本次解除质押后，爱尔医疗投资累计质押股份为611,241,045股，占其持股比例19.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600036348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","LU1242518857.USD","BK0096","BK0196","BK0188","300015","BK0200","BK0236","LU1242518931.SGD","BK0012","BK0028","LU0979878070.USD","LU1146622755.USD","LU1820825898.SGD","BK0114","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618313922","title":"股市必读：爱尔眼科（300015）3月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618313922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618313922?lang=zh_cn&edition=full","pubTime":"2026-03-12 01:04","pubTimestamp":1773248654,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，爱尔眼科报收于10.29元，下跌0.48%，换手率0.56%，成交量44.38万手，成交额4.57亿元。董秘最新回复投资者： 传出公司要去香港上市，就目前的市值来说，上h后市值港股估值打5折的不是没这个可能，请问公司出现这个情况，如何维护A股的权益？重大信息以公司公告为准。当日关注点来自交易信息汇总：3月11日主力资金净流入1380.88万元，显示主力对爱尔眼科的积极布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200000731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1242518857.USD","LU1242518931.SGD","BK0012","LU1146622755.USD","LU1820825898.SGD","300015","BK0188","BK0114","LU0979878070.USD","BK0096","BK0200","BK0077","BK0113","BK0196","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618643752","title":"新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2618643752","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618643752?lang=zh_cn&edition=full","pubTime":"2026-03-09 15:52","pubTimestamp":1773042746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月9日，据媒体报道，爱尔眼科(300015.SZ)正计划赴港上市。知情人士透露，这家中国最大的眼科连锁医院正在与顾问合作筹备股份出售事宜。IPO规模和时间等细节仍在商讨中。对此，爱尔眼科方面回应，以公告信息为准，重大事项都会发布公告。据其官网显示，爱尔眼科成立于2002年，并于2009年在深圳上市，截至2023年底，旗下运营着近900家眼科医院、眼科中心和诊所。其中大部分位于中国内地，此外在欧洲、东南亚和中国香港也设有诊所。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1146622755.USD","LU1820825898.SGD","LU1242518857.USD","300015","BK0012","BK0188","BK0028","LU1242518931.SGD","BK0196","BK0113","BK0077","BK0114","LU0979878070.USD","BK0236","BK0096","BK0200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617440683","title":"爱尔眼科：油价变化与眼科耗材相关度极低","url":"https://stock-news.laohu8.com/highlight/detail?id=2617440683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617440683?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:36","pubTimestamp":1772786170,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问石油涨价，对贵司的医疗耗材成本影响大吗？爱尔眼科回复：谢谢您对公司的关注。万物皆有联系，但油价变化与眼科耗材相关度极低。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0236","BK0028","LU1242518931.SGD","BK0113","BK0188","300015","BK0196","BK0096","BK0200","LU1146622755.USD","LU1820825898.SGD","LU1242518857.USD","LU0979878070.USD","BK0077","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346704","title":"爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346704","media":"朝阳永续","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616346704?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:39","pubTimestamp":1772530740,"startTime":"0","endTime":"0","summary":"管理层预计2026年收入增长将达到中位数，其中屈光和验光业务增长超过15%，白内障手术可能稍低。分业务来说：1) DRG/DIP和成本控制：爱尔眼科通过提高效率、优化病例组合和利用规模优势，成功抵消了潜在的价格压力，上海DRG试点医院在实施的头两年均实现了预算盈余。尽管宏观经济疲软导致全国屈光手术需求增长放缓，但公司通过技术升级和新程序采用，继续扩大市场份额，商业保险收入增长超过20%，为收入增长提供支持。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhpteii0768787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616857973","title":"爱尔眼科：成立多学科合作的老视学组","url":"https://stock-news.laohu8.com/highlight/detail?id=2616857973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616857973?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:31","pubTimestamp":1772436660,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月02日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200015683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","LU1242518857.USD","300015","BK0188","BK0114","BK0028","BK0196","LU1820825898.SGD","BK0077","LU1146622755.USD","BK0113","BK0012","LU0979878070.USD","BK0200","BK0236","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158917709","title":"巴伐利亚眼科全年净利润达4210万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158917709","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158917709?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:53","pubTimestamp":1772211200,"startTime":"0","endTime":"0","summary":"2月27日（路透社）—— 巴伐利亚诊所股份有限公司公布全年财务数据：*全年净利润为4210万欧元*全年营业收入达3.081亿欧元*全年税息折旧及摊销前利润（EBITDA）为8450万欧元。数据来源时间：2026年2月27日16:31:25.947 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0113","LU1242518857.USD","LU1242518931.SGD","BK0028","BK0077","BK0200","LU1146622755.USD","BK0114","LU0979878070.USD","LU1820825898.SGD","BK0096","BK0012","BK0188","BK0236","300015"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775766463195,"stockEarnings":[{"period":"1week","weight":-0.0145},{"period":"1month","weight":-0.0812},{"period":"3month","weight":-0.1625},{"period":"6month","weight":-0.2445},{"period":"1year","weight":-0.2501},{"period":"ytd","weight":-0.1289}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.0374},{"period":"6month","weight":0.0177},{"period":"1year","weight":0.2446},{"period":"ytd","weight":-0.0007}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"344788人(较上一季度增加0.27%)","perCapita":"23073股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":" 爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}